Opus Genetics IRD 深 滬
等待開盤 10-28 09:30:00 美东时间
3.46
+0.140
+4.22%
華盛通- 最 高3.53
- 今 開3.32
- 成交量 130.33万股
- 最 低 3.28
- 昨 收 3.32
- 總市值 2.88亿
- 52周最高 7.07
- 市盈率 靜 --
- 換手率 1.57%
- 52周最低 1.70
- 委 比 91.36%
- 總股本 8319.58万
- 歷史最高 23.08
- 量 比 1.03
- 振 幅 7.53%
- 歷史最低 0.65
- 每 手 1
- 風險率 1.16%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | Evercore维持SpaceX"跑赢大市"评级！目标价从230美元升至275美元
今日重点评级关注：Leerink Partners：维持First Tracks"跑赢大市"评级，目标价从70美元升至90美元；Keybanc：维持Absci"超配"评级，目标价从16美元升至20美元
10-19 18:42
Opus Genetics Presents Clinical Findings From OPGx-BEST1 And OPGx-LCA5 Gene Therapy Programs At Retina In Rio 2026; Phase 3 Clinical Trial Dosing For OPGx-LCA5 Expected In Q4 Of 2026
OPGx-BEST1 showed improved retinal sensitivity in 75% of evaluable participants in the initial low-dose Cohort 1 of the Company’s Phase 1/2 clinical trial, supporting further clinical development New BEST1 data analyses link retinal structure to visual function, enabling focus on regions most likely...
10-16 04:02
美股大行评级 | 花旗看高AMD至800美元！富国上调Meta目标价至1000美元
今日重点评级关注：Jones Trading：维持Opus Genetics"买入"评级，目标价从10美元升至17美元；Citizens：维持Rezolute"跑赢大市"评级，目标价从11美元升至15美元
10-07 17:30
Jones Trading Maintains Buy on Opus Genetics, Raises Price Target to $17
Jones Trading maintains Opus Genetics (NASDAQ:IRD) with a Buy and raises the price target from $10 to $17.
10-07 03:03
Small-cap stocks with strong momentum grades and triple-digit YTD gains
A group of U.S. small-cap stocks is flashing A+ momentum grades in the latest quantitative screen, with several names posting triple-digit gains year to date. Seeking Alpha's Quant Momentum Grade meas...
09-17 21:55
美股大行评级 | 齐声看好医药股！礼来、强生、默沙东目标价均获上调；小摩大幅上调Meta目标价至820美元
今日重点评级关注：康托·菲茨杰拉德：维持SOL Strategies"超配"评级，目标价从2.8美元升至6.2美元；康托·菲茨杰拉德：维持Sui Group Holdings"超配"评级，目标价从1.7美元升至3.4美元
09-11 14:30
美股大行评级 | 戴尔、Adobe获大行上调目标价；甲骨文绩前目标价遭调低
今日重点评级关注：富国银行：维持Pyxis Oncology"超配"评级，目标价从12美元升至19美元；Oppenheimer：维持Opus Genetics"跑赢大市"评级，目标价从10美元升至20美元
09-10 15:00
美股牛股 | 业绩股齐升！西格内特珠宝劲升24%，Q2盈利超预期26%；Academy、Flotek均升逾14%，双双上调业绩指引
业绩股齐升！西格内特珠宝劲升24%，Q2盈利超预期26%；Academy、Flotek均升逾14%，双双上调业绩指引>>
09-10 19:16
Caleres Posts Upbeat Q2 Earnings, Joins Opus Genetics, Flotek Industries And Other Big Stocks Moving Higher On Wednesday
U.S. stocks were lower, with the Dow Jones index falling around 400 points on Wednesday. Shares of Caleres Inc (NYSE:CAL) rose sharply after the company reported better-than-expected second-quarter financial results and raised its FY26 EPS guidance. Caleres reported quarterly earnings of 47 cents pe...
09-09 22:04
Opus Genetics Reports Positive OPGx-BEST1 Phase 1/2 Data
Opus Genetics ( ($IRD) ) just unveiled an announcement. On September 9, 2026, O...
09-09 19:59
